| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavonoids | 25 | 2020 | 87 | 6.660 |
Why?
|
| Glucuronides | 25 | 2020 | 29 | 6.590 |
Why?
|
| Glucuronosyltransferase | 20 | 2021 | 62 | 5.390 |
Why?
|
| Tandem Mass Spectrometry | 22 | 2020 | 293 | 4.010 |
Why?
|
| Genistein | 17 | 2012 | 39 | 3.430 |
Why?
|
| Intestinal Mucosa | 23 | 2019 | 814 | 2.950 |
Why?
|
| Intestinal Absorption | 22 | 2015 | 193 | 2.860 |
Why?
|
| Chromatography, Liquid | 14 | 2017 | 245 | 2.850 |
Why?
|
| Caco-2 Cells | 30 | 2020 | 97 | 2.590 |
Why?
|
| Isoflavones | 13 | 2009 | 43 | 2.420 |
Why?
|
| Phenols | 7 | 2012 | 57 | 2.240 |
Why?
|
| Chromatography, High Pressure Liquid | 19 | 2020 | 355 | 2.080 |
Why?
|
| Microsomes, Liver | 15 | 2020 | 100 | 2.000 |
Why?
|
| ATP-Binding Cassette Transporters | 8 | 2015 | 198 | 1.980 |
Why?
|
| Microsomes | 10 | 2010 | 40 | 1.760 |
Why?
|
| Sulfotransferases | 5 | 2017 | 27 | 1.700 |
Why?
|
| Biological Availability | 23 | 2021 | 151 | 1.570 |
Why?
|
| Rats | 39 | 2021 | 3686 | 1.530 |
Why?
|
| Liver | 13 | 2021 | 1852 | 1.460 |
Why?
|
| Plant Extracts | 5 | 2015 | 134 | 1.330 |
Why?
|
| Multidrug Resistance-Associated Proteins | 7 | 2016 | 26 | 1.320 |
Why?
|
| Intestines | 14 | 2021 | 613 | 1.250 |
Why?
|
| Neoplasm Proteins | 5 | 2015 | 713 | 1.220 |
Why?
|
| Biological Transport | 25 | 2012 | 363 | 1.190 |
Why?
|
| Colon | 4 | 2019 | 377 | 1.170 |
Why?
|
| Dinoprostone | 2 | 2019 | 70 | 1.170 |
Why?
|
| Flavones | 5 | 2012 | 10 | 1.160 |
Why?
|
| Celecoxib | 2 | 2019 | 33 | 1.120 |
Why?
|
| Flavonols | 4 | 2011 | 13 | 1.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2019 | 50 | 1.100 |
Why?
|
| Animals | 65 | 2022 | 35916 | 1.030 |
Why?
|
| Kinetics | 18 | 2017 | 1312 | 1.000 |
Why?
|
| Raloxifene Hydrochloride | 4 | 2021 | 18 | 0.970 |
Why?
|
| Models, Molecular | 4 | 2012 | 1128 | 0.920 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2015 | 1245 | 0.910 |
Why?
|
| Flavanones | 4 | 2012 | 8 | 0.850 |
Why?
|
| Apigenin | 8 | 2012 | 9 | 0.830 |
Why?
|
| Isoenzymes | 4 | 2011 | 227 | 0.820 |
Why?
|
| Glucuronidase | 3 | 2022 | 30 | 0.810 |
Why?
|
| Molecular Structure | 10 | 2015 | 323 | 0.810 |
Why?
|
| Cytochrome P-450 Enzyme System | 5 | 2015 | 115 | 0.780 |
Why?
|
| Administration, Oral | 11 | 2017 | 712 | 0.770 |
Why?
|
| Ginsenosides | 2 | 2012 | 17 | 0.740 |
Why?
|
| Recombinant Proteins | 9 | 2016 | 1419 | 0.720 |
Why?
|
| Protein Isoforms | 7 | 2011 | 431 | 0.690 |
Why?
|
| Metabolic Detoxication, Phase II | 3 | 2015 | 14 | 0.680 |
Why?
|
| Hydroxyl Radical | 1 | 2020 | 13 | 0.660 |
Why?
|
| Anticarcinogenic Agents | 3 | 2012 | 48 | 0.650 |
Why?
|
| Serum Albumin, Bovine | 1 | 2020 | 56 | 0.650 |
Why?
|
| Rats, Wistar | 8 | 2020 | 332 | 0.650 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2010 | 49 | 0.640 |
Why?
|
| Intestine, Small | 3 | 2008 | 317 | 0.610 |
Why?
|
| Perfusion | 10 | 2020 | 209 | 0.610 |
Why?
|
| Diterpenes | 2 | 2015 | 29 | 0.560 |
Why?
|
| Camptothecin | 2 | 2016 | 74 | 0.560 |
Why?
|
| Models, Biological | 9 | 2012 | 1522 | 0.550 |
Why?
|
| Pharmaceutical Preparations | 3 | 2012 | 87 | 0.550 |
Why?
|
| Mixed Function Oxygenases | 4 | 2003 | 36 | 0.530 |
Why?
|
| Polymyxin B | 3 | 2012 | 47 | 0.520 |
Why?
|
| Dipeptidases | 5 | 2003 | 15 | 0.510 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 35 | 0.500 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 233 | 0.500 |
Why?
|
| Lactones | 2 | 2015 | 37 | 0.500 |
Why?
|
| Mangifera | 1 | 2015 | 2 | 0.490 |
Why?
|
| Gallic Acid | 1 | 2015 | 4 | 0.490 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 644 | 0.490 |
Why?
|
| Hydrolyzable Tannins | 1 | 2015 | 4 | 0.490 |
Why?
|
| Seeds | 1 | 2015 | 43 | 0.480 |
Why?
|
| Reproducibility of Results | 8 | 2017 | 3047 | 0.470 |
Why?
|
| Stilbenes | 1 | 2015 | 38 | 0.470 |
Why?
|
| Humans | 70 | 2020 | 133242 | 0.470 |
Why?
|
| Curcumin | 1 | 2015 | 43 | 0.470 |
Why?
|
| Substrate Specificity | 7 | 2012 | 309 | 0.470 |
Why?
|
| Estrone | 2 | 2004 | 13 | 0.440 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2011 | 21 | 0.440 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 822 | 0.440 |
Why?
|
| Male | 40 | 2020 | 65435 | 0.430 |
Why?
|
| Cholestasis | 1 | 2016 | 157 | 0.430 |
Why?
|
| Antineoplastic Agents | 5 | 2011 | 1849 | 0.430 |
Why?
|
| Dietary Supplements | 2 | 2010 | 484 | 0.430 |
Why?
|
| Biomarkers | 5 | 2019 | 3411 | 0.410 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 2161 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 607 | 0.390 |
Why?
|
| Panax | 1 | 2012 | 7 | 0.390 |
Why?
|
| Estrous Cycle | 1 | 2012 | 36 | 0.390 |
Why?
|
| Lactase-Phlorizin Hydrolase | 2 | 2012 | 21 | 0.380 |
Why?
|
| Pterocarpans | 2 | 2011 | 2 | 0.380 |
Why?
|
| Dogs | 6 | 2016 | 669 | 0.370 |
Why?
|
| Sulfur Compounds | 1 | 2011 | 4 | 0.370 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 155 | 0.370 |
Why?
|
| Alkaloids | 3 | 2011 | 37 | 0.360 |
Why?
|
| Cephalosporins | 4 | 1996 | 142 | 0.360 |
Why?
|
| Quinolizines | 2 | 2011 | 7 | 0.350 |
Why?
|
| Trifolium | 2 | 2008 | 2 | 0.350 |
Why?
|
| Hot Temperature | 2 | 2008 | 147 | 0.340 |
Why?
|
| Hypericum | 1 | 2010 | 1 | 0.340 |
Why?
|
| Quinazolines | 2 | 2004 | 185 | 0.330 |
Why?
|
| Coumarins | 2 | 2015 | 23 | 0.330 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2010 | 43 | 0.330 |
Why?
|
| Drug Interactions | 6 | 2010 | 252 | 0.320 |
Why?
|
| Estrogens | 1 | 2012 | 521 | 0.320 |
Why?
|
| Tissue Distribution | 6 | 2012 | 397 | 0.320 |
Why?
|
| Mice | 16 | 2017 | 18888 | 0.320 |
Why?
|
| Sulfates | 3 | 2016 | 36 | 0.320 |
Why?
|
| Gastrointestinal Tract | 3 | 2022 | 240 | 0.320 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 715 | 0.310 |
Why?
|
| Phytoestrogens | 2 | 2007 | 13 | 0.310 |
Why?
|
| Biotransformation | 5 | 2012 | 56 | 0.310 |
Why?
|
| Hydrolysis | 6 | 2012 | 161 | 0.300 |
Why?
|
| Injections, Intravenous | 5 | 2012 | 250 | 0.300 |
Why?
|
| Epimedium | 1 | 2008 | 1 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 6 | 2012 | 2586 | 0.290 |
Why?
|
| Nucleosides | 3 | 2004 | 19 | 0.280 |
Why?
|
| Quantitative Structure-Activity Relationship | 3 | 2012 | 15 | 0.280 |
Why?
|
| Organic Anion Transporters | 3 | 2020 | 21 | 0.270 |
Why?
|
| HeLa Cells | 3 | 2015 | 838 | 0.270 |
Why?
|
| Morphinans | 1 | 2006 | 2 | 0.260 |
Why?
|
| Bridged-Ring Compounds | 1 | 2006 | 17 | 0.260 |
Why?
|
| Benzoates | 1 | 2006 | 23 | 0.260 |
Why?
|
| Mice, Knockout | 6 | 2015 | 3978 | 0.250 |
Why?
|
| Glucosides | 1 | 2006 | 48 | 0.250 |
Why?
|
| Madin Darby Canine Kidney Cells | 2 | 2016 | 11 | 0.250 |
Why?
|
| Bile | 3 | 2012 | 46 | 0.250 |
Why?
|
| Up-Regulation | 1 | 2009 | 897 | 0.250 |
Why?
|
| Cephalexin | 2 | 1996 | 7 | 0.250 |
Why?
|
| Inactivation, Metabolic | 2 | 2016 | 28 | 0.250 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2004 | 455 | 0.250 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 2005 | 10 | 0.240 |
Why?
|
| Permeability | 3 | 2012 | 131 | 0.240 |
Why?
|
| Dipeptides | 4 | 1995 | 64 | 0.230 |
Why?
|
| Biological Products | 1 | 2007 | 137 | 0.230 |
Why?
|
| Food Labeling | 1 | 2004 | 11 | 0.230 |
Why?
|
| Soybean Proteins | 1 | 2004 | 17 | 0.230 |
Why?
|
| Rats, Inbred F344 | 3 | 2021 | 99 | 0.230 |
Why?
|
| Binding Sites | 3 | 2012 | 1360 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 310 | 0.220 |
Why?
|
| Area Under Curve | 4 | 2012 | 326 | 0.220 |
Why?
|
| Polyphenols | 3 | 2010 | 24 | 0.220 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 596 | 0.220 |
Why?
|
| Species Specificity | 4 | 2011 | 561 | 0.220 |
Why?
|
| Methionine | 2 | 1994 | 105 | 0.220 |
Why?
|
| Linear Models | 2 | 2016 | 718 | 0.210 |
Why?
|
| Absorption | 3 | 2012 | 52 | 0.210 |
Why?
|
| Ginkgo biloba | 1 | 2003 | 12 | 0.210 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2003 | 49 | 0.200 |
Why?
|
| Precision Medicine | 2 | 2017 | 361 | 0.200 |
Why?
|
| Carrier Proteins | 3 | 2005 | 1071 | 0.200 |
Why?
|
| Injections, Intraperitoneal | 2 | 2012 | 71 | 0.200 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2007 | 196 | 0.190 |
Why?
|
| Propionates | 3 | 2009 | 33 | 0.190 |
Why?
|
| Metabolic Clearance Rate | 3 | 2012 | 143 | 0.180 |
Why?
|
| Feces | 2 | 2016 | 786 | 0.180 |
Why?
|
| DNA, Complementary | 3 | 2003 | 464 | 0.180 |
Why?
|
| Cytochrome P-450 CYP3A | 4 | 2012 | 50 | 0.180 |
Why?
|
| Catalytic Domain | 2 | 2012 | 178 | 0.170 |
Why?
|
| Hepatobiliary Elimination | 1 | 2020 | 1 | 0.170 |
Why?
|
| Emodin | 2 | 2010 | 2 | 0.170 |
Why?
|
| Cell Membrane Permeability | 4 | 2004 | 75 | 0.170 |
Why?
|
| Quinolines | 3 | 2009 | 119 | 0.170 |
Why?
|
| Enterohepatic Circulation | 1 | 2020 | 11 | 0.170 |
Why?
|
| Membrane Transport Proteins | 3 | 2015 | 183 | 0.170 |
Why?
|
| Cell Line | 6 | 2015 | 2830 | 0.170 |
Why?
|
| Portal Vein | 1 | 2020 | 91 | 0.160 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 2763 | 0.160 |
Why?
|
| Protein Conformation | 2 | 2012 | 858 | 0.160 |
Why?
|
| Temperature | 5 | 2004 | 323 | 0.160 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1999 | 108 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 1999 | 102 | 0.150 |
Why?
|
| Peptides | 4 | 1996 | 854 | 0.150 |
Why?
|
| Gene Silencing | 2 | 2011 | 244 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2020 | 241 | 0.150 |
Why?
|
| Leukotriene C4 | 2 | 2011 | 4 | 0.150 |
Why?
|
| In Vitro Techniques | 4 | 2009 | 915 | 0.150 |
Why?
|
| Cattle | 1 | 2020 | 584 | 0.150 |
Why?
|
| Reference Standards | 2 | 2010 | 245 | 0.150 |
Why?
|
| Thymidylate Synthase | 1 | 1998 | 21 | 0.150 |
Why?
|
| Prodrugs | 3 | 2003 | 64 | 0.150 |
Why?
|
| Genetic Vectors | 2 | 1999 | 959 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2020 | 816 | 0.140 |
Why?
|
| Limit of Detection | 2 | 2015 | 77 | 0.140 |
Why?
|
| Cyclosporine | 2 | 2011 | 128 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 996 | 0.140 |
Why?
|
| Midazolam | 2 | 2012 | 45 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 4 | 2011 | 1098 | 0.140 |
Why?
|
| Kidney | 2 | 2016 | 1346 | 0.130 |
Why?
|
| Isotope Labeling | 1 | 2017 | 105 | 0.130 |
Why?
|
| Lipase | 1 | 1997 | 97 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 1598 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 810 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 152 | 0.130 |
Why?
|
| Biological Assay | 1 | 2017 | 111 | 0.130 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1996 | 40 | 0.130 |
Why?
|
| Swine, Miniature | 1 | 2016 | 53 | 0.130 |
Why?
|
| Phenylalanine | 3 | 2000 | 133 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2017 | 630 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2017 | 1402 | 0.120 |
Why?
|
| Tetrahydroisoquinolines | 1 | 1995 | 5 | 0.120 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 166 | 0.120 |
Why?
|
| Isoquinolines | 1 | 1995 | 41 | 0.120 |
Why?
|
| Epithelium | 5 | 1994 | 362 | 0.120 |
Why?
|
| Carcinogens | 3 | 2011 | 135 | 0.120 |
Why?
|
| Stereoisomerism | 2 | 2011 | 122 | 0.120 |
Why?
|
| Isomerism | 2 | 2011 | 28 | 0.120 |
Why?
|
| Biocatalysis | 2 | 2012 | 35 | 0.120 |
Why?
|
| Osmolar Concentration | 2 | 2011 | 177 | 0.110 |
Why?
|
| Cells, Cultured | 5 | 2011 | 3124 | 0.110 |
Why?
|
| Jejunum | 3 | 2012 | 132 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 221 | 0.110 |
Why?
|
| Zidovudine | 1 | 1993 | 23 | 0.100 |
Why?
|
| Enzyme Stability | 2 | 2007 | 60 | 0.100 |
Why?
|
| Thymidine | 1 | 1993 | 54 | 0.100 |
Why?
|
| Verapamil | 2 | 2011 | 50 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 3781 | 0.100 |
Why?
|
| Amino Acids | 3 | 1994 | 683 | 0.100 |
Why?
|
| Teichoic Acids | 1 | 2012 | 10 | 0.100 |
Why?
|
| Diketopiperazines | 1 | 2012 | 4 | 0.100 |
Why?
|
| Swine | 1 | 2016 | 1199 | 0.100 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2012 | 9 | 0.100 |
Why?
|
| Phloretin | 1 | 2012 | 3 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 47 | 0.100 |
Why?
|
| Arylsulfotransferase | 1 | 2012 | 4 | 0.100 |
Why?
|
| Kaempferols | 1 | 2012 | 6 | 0.100 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 27 | 0.090 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2012 | 35 | 0.090 |
Why?
|
| Aconitine | 1 | 2011 | 8 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2011 | 335 | 0.090 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2011 | 6 | 0.090 |
Why?
|
| Membrane Transport Modulators | 1 | 2011 | 5 | 0.090 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 87 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 188 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2012 | 74 | 0.090 |
Why?
|
| Inflammation | 2 | 2017 | 1546 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 65 | 0.090 |
Why?
|
| Time Factors | 5 | 2012 | 6527 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 3937 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2012 | 828 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 136 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 248 | 0.090 |
Why?
|
| Solubility | 1 | 2011 | 137 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 105 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 162 | 0.090 |
Why?
|
| Glycosides | 1 | 2011 | 9 | 0.090 |
Why?
|
| Cytosol | 1 | 2011 | 166 | 0.090 |
Why?
|
| Catalysis | 1 | 2011 | 138 | 0.090 |
Why?
|
| Calibration | 1 | 2011 | 99 | 0.090 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 389 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 308 | 0.080 |
Why?
|
| Acinetobacter baumannii | 1 | 2011 | 47 | 0.080 |
Why?
|
| Cell Division | 3 | 1999 | 767 | 0.080 |
Why?
|
| Klebsiella pneumoniae | 1 | 2011 | 85 | 0.080 |
Why?
|
| Testosterone | 3 | 2009 | 620 | 0.080 |
Why?
|
| Drug Stability | 4 | 1999 | 62 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2011 | 99 | 0.080 |
Why?
|
| Levodopa | 1 | 1990 | 94 | 0.080 |
Why?
|
| Female | 12 | 2021 | 71474 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2012 | 628 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 84 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 123 | 0.080 |
Why?
|
| Cathartics | 1 | 2010 | 31 | 0.080 |
Why?
|
| Methotrexate | 1 | 2012 | 352 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 778 | 0.080 |
Why?
|
| Dipyridamole | 1 | 2009 | 21 | 0.080 |
Why?
|
| Leukotriene Antagonists | 1 | 2009 | 18 | 0.080 |
Why?
|
| Sodium | 3 | 1998 | 293 | 0.080 |
Why?
|
| Random Allocation | 1 | 2010 | 437 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 177 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 317 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 51 | 0.080 |
Why?
|
| Butanols | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mannitol | 3 | 2000 | 49 | 0.080 |
Why?
|
| Rats, Gunn | 1 | 2009 | 3 | 0.080 |
Why?
|
| Glucuronic Acid | 1 | 2009 | 14 | 0.080 |
Why?
|
| Berberine | 1 | 2009 | 10 | 0.080 |
Why?
|
| Methyldopa | 1 | 1989 | 4 | 0.080 |
Why?
|
| Captopril | 1 | 1988 | 25 | 0.080 |
Why?
|
| Indomethacin | 1 | 2009 | 84 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2004 | 923 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2012 | 383 | 0.070 |
Why?
|
| Azetidines | 1 | 2009 | 64 | 0.070 |
Why?
|
| Hydroxylation | 2 | 2011 | 50 | 0.070 |
Why?
|
| Hesperidin | 1 | 2008 | 2 | 0.070 |
Why?
|
| Glucosidases | 1 | 2008 | 3 | 0.070 |
Why?
|
| Ezetimibe | 1 | 2009 | 94 | 0.070 |
Why?
|
| Prenylation | 1 | 2008 | 2 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 1990 | 401 | 0.070 |
Why?
|
| Fungal Proteins | 1 | 2008 | 143 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2009 | 393 | 0.070 |
Why?
|
| Monoterpenes | 1 | 2006 | 5 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1704 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2007 | 439 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2009 | 469 | 0.060 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 223 | 0.060 |
Why?
|
| Digoxin | 1 | 2006 | 43 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2009 | 239 | 0.060 |
Why?
|
| Sex Factors | 1 | 2010 | 1355 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2012 | 1034 | 0.060 |
Why?
|
| Transfection | 2 | 1999 | 1083 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 786 | 0.060 |
Why?
|
| Half-Life | 1 | 2005 | 160 | 0.060 |
Why?
|
| Plants | 1 | 2005 | 52 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 1158 | 0.060 |
Why?
|
| Protons | 2 | 1996 | 97 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 676 | 0.060 |
Why?
|
| Washington | 1 | 2004 | 35 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 612 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1605 | 0.060 |
Why?
|
| Biliary Tract | 1 | 2004 | 13 | 0.050 |
Why?
|
| Serum | 1 | 2004 | 46 | 0.050 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2003 | 1 | 0.050 |
Why?
|
| Phenacetin | 1 | 2003 | 3 | 0.050 |
Why?
|
| Acetophenones | 1 | 2003 | 13 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13072 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 107 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1994 | 189 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 50 | 0.050 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2003 | 67 | 0.050 |
Why?
|
| Chromatography, Gel | 1 | 2003 | 96 | 0.050 |
Why?
|
| Models, Animal | 1 | 2005 | 480 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 267 | 0.050 |
Why?
|
| Methylation | 1 | 2003 | 232 | 0.050 |
Why?
|
| Culture Media | 2 | 2012 | 183 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2003 | 262 | 0.050 |
Why?
|
| Propranolol | 2 | 2000 | 113 | 0.050 |
Why?
|
| beta-Glucosidase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2002 | 69 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 267 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1928 | 0.050 |
Why?
|
| 2,4-Dinitrophenol | 2 | 1992 | 3 | 0.050 |
Why?
|
| Dinitrophenols | 2 | 1992 | 5 | 0.050 |
Why?
|
| Glucuronates | 1 | 2021 | 6 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 909 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2007 | 554 | 0.050 |
Why?
|
| Catheterization | 1 | 2002 | 239 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 2002 | 79 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 2314 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2000 | 54 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2002 | 274 | 0.040 |
Why?
|
| Sympatholytics | 1 | 1999 | 2 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 1597 | 0.040 |
Why?
|
| Diuretics, Osmotic | 1 | 1999 | 4 | 0.040 |
Why?
|
| Drug Carriers | 2 | 1992 | 119 | 0.040 |
Why?
|
| Middle Aged | 2 | 2017 | 29026 | 0.040 |
Why?
|
| Nifedipine | 1 | 1999 | 22 | 0.040 |
Why?
|
| GABA Modulators | 1 | 1999 | 11 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 66 | 0.040 |
Why?
|
| Tritium | 1 | 1999 | 164 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2745 | 0.040 |
Why?
|
| Piperidines | 1 | 2021 | 237 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 114 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 31746 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 1999 | 353 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 21486 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 3147 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 254 | 0.040 |
Why?
|
| Indoles | 1 | 1999 | 200 | 0.040 |
Why?
|
| Warfarin | 1 | 1999 | 134 | 0.040 |
Why?
|
| Purines | 1 | 1998 | 118 | 0.040 |
Why?
|
| Pyridines | 1 | 1999 | 249 | 0.030 |
Why?
|
| Ileum | 1 | 1998 | 130 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1999 | 270 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 6314 | 0.030 |
Why?
|
| Duodenum | 1 | 1998 | 113 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 569 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1053 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 1996 | 10 | 0.030 |
Why?
|
| Xenobiotics | 1 | 1996 | 28 | 0.030 |
Why?
|
| Liposomes | 1 | 1997 | 206 | 0.030 |
Why?
|
| Diffusion | 1 | 1995 | 58 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 1273 | 0.030 |
Why?
|
| Neoplasms | 1 | 2010 | 2975 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1995 | 47 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 1999 | 481 | 0.030 |
Why?
|
| Ouabain | 1 | 1994 | 22 | 0.030 |
Why?
|
| Amiloride | 1 | 1994 | 28 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 1028 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2015 | 142 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2950 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1999 | 627 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 1994 | 40 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1994 | 6 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 96 | 0.030 |
Why?
|
| Insulin | 1 | 1999 | 1226 | 0.030 |
Why?
|
| Gluconates | 1 | 2012 | 5 | 0.020 |
Why?
|
| Recycling | 1 | 2012 | 5 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2012 | 10 | 0.020 |
Why?
|
| Uranyl Nitrate | 1 | 2012 | 2 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2011 | 2558 | 0.020 |
Why?
|
| Sodium Azide | 1 | 1992 | 4 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2012 | 27 | 0.020 |
Why?
|
| Azides | 1 | 1992 | 8 | 0.020 |
Why?
|
| Ions | 1 | 1992 | 22 | 0.020 |
Why?
|
| Drug Dosage Calculations | 1 | 2012 | 23 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 1992 | 42 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 91 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 130 | 0.020 |
Why?
|
| DNA Topoisomerase IV | 1 | 2012 | 13 | 0.020 |
Why?
|
| Benzoxepins | 1 | 2011 | 1 | 0.020 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2011 | 5 | 0.020 |
Why?
|
| DNA Gyrase | 1 | 2012 | 26 | 0.020 |
Why?
|
| Limonins | 1 | 2011 | 3 | 0.020 |
Why?
|
| Ofloxacin | 1 | 2012 | 32 | 0.020 |
Why?
|
| Glucose | 2 | 2000 | 914 | 0.020 |
Why?
|
| Levofloxacin | 1 | 2012 | 48 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 60 | 0.020 |
Why?
|
| Quinolones | 1 | 2012 | 58 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2011 | 53 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 155 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 417 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 426 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 302 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 195 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 883 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 544 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 33 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 40 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 312 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2866 | 0.020 |
Why?
|
| Excipients | 1 | 1988 | 11 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2009 | 56 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 294 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 806 | 0.020 |
Why?
|
| Basidiomycota | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 641 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1583 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 93 | 0.020 |
Why?
|
| beta-Lactams | 1 | 1988 | 56 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1663 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2115 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 231 | 0.020 |
Why?
|
| Protein Binding | 1 | 1990 | 1833 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 510 | 0.020 |
Why?
|
| Pharmacokinetics | 1 | 2002 | 15 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4818 | 0.010 |
Why?
|
| Cimetidine | 1 | 2000 | 14 | 0.010 |
Why?
|
| Erythromycin | 1 | 2000 | 21 | 0.010 |
Why?
|
| Atenolol | 1 | 2000 | 43 | 0.010 |
Why?
|
| Insulin Lispro | 1 | 1999 | 2 | 0.010 |
Why?
|
| Cresols | 1 | 1999 | 6 | 0.010 |
Why?
|
| Mammals | 1 | 2000 | 282 | 0.010 |
Why?
|
| Adsorption | 1 | 1999 | 37 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 4848 | 0.010 |
Why?
|